Last updated on September 2018

Dose-finding Study to Assess the Efficacy Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection


Brief description of study

The purpose of this study is to support the selection of a safe and tolerable tobramycin inhalation powder (TIP) dose, and regimen that exhibits effective bacterial reduction of P. aeruginosa in non-cystic fibrosis bronchiectasis (BE) patients with P. aeruginosa colonization.

Detailed Study Description

This is a blinded, randomized, dose- and regimen finding trial where active TIP doses or placebo is given in addition to the local standard care.

Clinical Study Identifier: NCT02712983

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Bruxelles, Belgium
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Nice, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Milan, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Barcelona, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Valencia, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Cambridge, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Penarth, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Dundee, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
London, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Leuven, Belgium
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bayonne, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Grenoble, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Paris, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Toulouse, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Essen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Berlin, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Frankfurt, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Hannover, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Leipzig, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Genova, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Monza, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Pisa, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Pordenone, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Pavia, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Scafati, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Rotterdam, Netherlands
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Valladolid, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Huntingdon, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Belfast, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Birmingham, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Edinburgh, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Glasgow, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Lancaster, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Leeds, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Newcastle upon Tyne, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Southampton, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Montpellier cedex 5, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Neu-Isenburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Barakaldo, Spain
  Connect »